Köle Emre, Akar Bertan, Doğan Yasemin, Yalçınkaya Leylim, Doger Emek, Çalışkan Eray
Department of Obstetrics and Gynecology, Alanya Alaaddin Keykubat University School of Medicine, Antalya, Türkiye.
Department of Obstetrics and Gynecology, Private Medar Hospital, Kocaeli, Türkiye.
J Perinat Med. 2024 Jun 19;52(7):706-711. doi: 10.1515/jpm-2024-0049. Print 2024 Sep 25.
The aim of this study was to compare the efficacy of cervical cerclage with spontaneous follow-up strategy on pregnancy duration and neonatal outcomes in women with visible or prolapsed fetal membranes.
Patients who were referred to a single tertiary care centre between 1st January 2017 and 31st December 2022 were included in this comparative, retrospective cohort study. Patients were divided into two groups, those undergoing cerclage and those followed with no-cerclage. The range of pregnancy weeks for cerclage is between 18th and 27+6 weeks.
A total of 106 cases were reviewed and nine were excluded. Based on shared decision making, cervical cerclage was performed in 76 patients (78.3 %) and 21 patients (21.6 %) were medically treated in no-cerclage group if there was no early rupture of the fetal membranes. The gestational age at delivery was 29.8 ± 6 [median=30 (19-38)] weeks in the cerclage group and 25.8 ± 2.9 [median=25 (19-32)] weeks in the no-cerclage group (p=0.004). Pregnancy prolongation was significantly longer in the cerclage group compared to the no-cerclage group (55 ± 48.6 days [median=28 (3-138)] vs. 12 ± 17.9 days [median=9 (1-52)]; p<0.001). Take home baby rate was 58/76 (76.3 %) in cerclage group vs. 8/21 (38 %) in no-cerclage group. In the post-24 week cerclage group the absolute risk reduction for pregnancy loss was 50 % (95 % CI=21.7-78.2).
Cervical cerclage applied before and after 24 weeks (until 27+6 weeks) increased take home baby rate in women with visible or prolapsed fetal membranes without increasing adverse maternal outcome when compared with no-cerclage group.
本研究旨在比较宫颈环扎术与自然随访策略对胎膜可见或脱垂女性的妊娠持续时间和新生儿结局的疗效。
本比较性回顾性队列研究纳入了2017年1月1日至2022年12月31日期间转诊至一家三级医疗中心的患者。患者分为两组,即接受环扎术的患者和未接受环扎术的患者。环扎术的孕周范围为18周至27⁺⁶周。
共审查了106例病例,排除9例。基于共同决策,76例患者(78.3%)接受了宫颈环扎术,未接受环扎术组中如果没有胎膜早破,21例患者(21.6%)接受了药物治疗。环扎术组的分娩孕周为29.8±6[中位数=30(19 - 38)]周,未接受环扎术组为25.8±2.9[中位数=25(19 - 32)]周(p = 0.004)。与未接受环扎术组相比,环扎术组的妊娠延长明显更长(55±48.6天[中位数=28(3 - 138)]对12±17.9天[中位数=9(1 - 52)];p<0.001)。环扎术组的带回家婴儿率为58/76(76.3%),未接受环扎术组为8/21(38%)。在24周后环扎术组中,妊娠丢失的绝对风险降低了50%(95%CI = 21.7 - 78.2)。
与未接受环扎术组相比,在24周前后(直至27⁺⁶周)进行宫颈环扎术可提高胎膜可见或脱垂女性的带回家婴儿率,且不增加孕产妇不良结局。